Reduced CD4+T Cell CXCR3 Expression in Patients With Allergic Rhinitis

Front Immunol. 2020 Nov 3:11:581180. doi: 10.3389/fimmu.2020.581180. eCollection 2020.

Abstract

While T cells are considered to play a primary role in IgE-mediated atopic diseases, little is known about the systemic variations of T cell subsets from patients with allergic rhinitis (AR). To elucidate the characteristics of peripheral T cells, we analyzed natural killer, B cell, and T cell populations, performed T cell subset construction, and assessed chemokine receptor and associated serum cytokine expression in 25 AR patients and 20 healthy controls. Our results revealed increased levels of CD4+T cells, serum interleukin (IL)-10, IL-6, and interferon (IFN)-γ, and reduced Th1 and Th17 subsets, identified by their chemokine receptors, in AR patients. These results suggest a systemic activation of T cell responses in AR. We further demonstrated that AR patients exhibit significantly reduced CD4+T cell CXCR3 expression, especially in patients with moderate-severe disease severity, demonstrating that CXCR3 is a potential key molecule that hinders the Th1/Th2 balance in AR pathology. Overall, systemic T cell activation occurred in AR patients and CXCR3 dramatically decreased in CD4+T cells, which may ultimately be used as a potential disease and/or therapeutic target.

Keywords: CD4+ T Cell; CXCR3; T cell subset; allergic rhinitis; cytokines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4-Positive T-Lymphocytes / immunology*
  • Case-Control Studies
  • Female
  • Humans
  • Interferon-gamma / blood
  • Interleukin-10 / blood
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Receptors, CXCR3 / blood*
  • Rhinitis, Allergic / immunology*
  • Severity of Illness Index
  • Th1 Cells / immunology
  • Th1-Th2 Balance
  • Th17 Cells / immunology
  • Young Adult

Substances

  • CXCR3 protein, human
  • IL10 protein, human
  • IL6 protein, human
  • Interleukin-6
  • Receptors, CXCR3
  • Interleukin-10
  • Interferon-gamma